Mineralocorticoid receptor overactivation in heart failure with preserved ejection fraction
Listen to this summary
The authors investigate the role of mineralocorticoid receptor (MR) overactivation in the development and progression of heart failure with preserved ejection fraction (HFpEF), exploring its mechanistic pathways and potential therapeutic interventions. They highlight how MR overactivation contributes to key features of HFpEF and suggest that targeting this pathway with MR antagonists or inhibitors could improve patient outcomes. The paper calls for a reevaluation of treatment strategies in clinical practice to address MR overactivation in HFpEF.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from European heart journal
View all →Aug 7, 2026 · European heart journal
Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study
Aug 7, 2026 · European heart journal
Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies
Aug 7, 2026 · European heart journal
Bruton's tyrosine kinase inhibitors and cardiovascular risk: a meta-analysis
Aug 5, 2026 · European heart journal
Risk factors and coronary events: attenuation of the association in secondary prevention
Aug 5, 2026 · European heart journal
Adverse pregnancy outcomes in successive pregnancies and maternal cardiovascular mortality: a Norwegian nationwide study
Aug 5, 2026 · European heart journal
Periodontitis, epicardial adipose tissue and coronary events: the Swedish Cardiopulmonary Bioimage Study
More in Internal Medicine
View all →Aug 9, 2026 · American heart journal
Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial
Aug 8, 2026 · JACC. Clinical electrophysiology
LMNA Deficiency Reveals a Role for SK3 Channel Dysfunction in Atrioventricular Block
Aug 8, 2026 · JACC. Clinical electrophysiology
Atrial Fibrillation Initiation Arises From Reentry at Patient-Specific Regions With Steep Repolarization Gradients Identified During Sinus Rhythm
Aug 7, 2026 · American heart journal
HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics
Aug 7, 2026 · The American journal of medicine
Consumption of Ultra-Processed Foods and Increased Risks of Prostate Cancer in a Random Sample of United States Adults
Aug 7, 2026 · JACC. Clinical electrophysiology
The Emergence of Sports Electrophysiology: Care of Athletes With Arrhythmias, From the ACC's Sports and Exercise Cardiology Leadership Council
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


